Respiratory Inhalers Market Size is Expected to Reach US$46,984.1 Million with a CAGR of 4.5% by 2028 | Cipla Ltd., GlaxoSmithKline plc., Koninklijke Philips NV, Merck & Co.,

Respiratory Inhalers Market

Market overview

Breathing inhalers are used with a complementary spacer or holding chamber device, to reduce buildup in the throat and mouth and to meet the need for precise synchronization of the start of inhalation with the actuation of the device.

Statistics:

The global respiratory inhaler market is estimated at US$32,921.8 million in terms of value and is expected to reach US$46,984.1 million by the end of 2027.

Drivers

Rising adoption of combination therapies including trial combination therapy for chronic obstructive pulmonary disease (COPD) is expected to propel the growth of the global respiratory inhalers market over the forecast period. Such therapies provide various diseases, including greater reliability in complex patients, increased efficacy, and easy reimbursement policies associated with the therapy.

Opportunities

Smart inhaler technology is a new technology developed to help patients control their doses and offers various other features. Some devices with smart inhaler technology are able to read environmental pollution, in terms of air quality, and can alert the patient to the presence of asthma triggers in the air. Propeller Health, a US-based company, has started supplementing drugs with this technology. They connected an inhaler with Bluetooth transmitter to provide smartphone connectivity. This technology can keep track of the frequency of an asthma attack in a patient and the causes behind the triggers and provide it to their respective healthcare professional.

๐ ๐ž๐ญ ๐Œ๐จ๐ซ๐ž ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ https://www.coherentmarketinsights.com/insight/request-sample/227

Constraints

Lack of skilled physicians and pulmonologists is expected to hamper the growth of the global respiratory inhalers market over the forecast period.

Key points to remember

Metered Dose Inhalers sub-segment within Product Type segment in the global Respiratory Inhalers Market was valued at US$ 22,360.9 Million in 2018 and is projected to reach US$ 33,825.0 Million by 2027 at a CAGR of 4.5% over the forecast period.

The metered dose inhaler delivers a specific dose of medicine in the form of an aerosol. The metered-dose inhaler was the first inhaler marketed in the 1950s and remains the most commonly used inhaler in the world. Moreover, its low cost compared to other advanced inhalers such as dry powder inhaler and nebulizer, gives it a competitive advantage, especially in developing economies like India, China and Brazil, where cost is one of the critical factors.

The hand-operated inhaler sub-segment of the technology segment held a dominant position in the global respiratory inhaler market in 2018, accounting for 93.1% share in terms of value, followed by digitally controlled inhalers.

Hand-held inhalers are the most common type of respiratory inhaler. In manual inhalers, medication is stored in a pressurized canister as a solution, which also contains a propellant. The most commonly used propellant is hydrofluoroalkane (HFA), which is environmentally friendly.

The asthma sub-segment within the disease indications segment held a dominant position in the global respiratory inhaler market in 2018, accounting for 60.4% share in terms of value, followed by COPD and pulmonary arterial hypertension, respectively.

๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐–๐ข๐ญ๐ก ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐–๐ข๐ญ๐ก ๐…๐ฅ๐š๐ญ ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐Ž๐…๐… ๐…๐ฅ๐š๐ญ ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐Ž๐…๐… ๐Ž๐…๐… ๐…๐ฅ๐š๐ญ ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐–๐ข๐ญ๐ก ๐–๐ข๐ญ๐ก ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… ๐Ž๐…๐… https://www.coherentmarketinsights.com/promo/buynow/227

Asthma treatment product launches are expected to support the market growth over the forecast period. For example, in January 2017, the US FDA approved AstraZenecaโ€™s Symbicort (budesonide/formoterol fumarate dihydrate), a metered-dose inhaler for the treatment of asthma in pediatric patients 6-12 years of age.

Market trends

The increase in R&D activities related to the correct use of inhalers is expected to propel the market growth. For example, in September 2018, researchers at the University of Helsinki, Finland reported on an investigation of non-verbal demonstration videos as a method of teaching inhaler-naive people how to use a dry powder inhaler ( DPI).

The market is also seeing the launch of devices to track metered dose inhaler (MDI) usage pattern. For example, in November 2019, Lupine Ltd. launched a device โ€“ Adhero โ€“ to track the pattern of metered-dose inhaler (MDI) use by patients with chronic respiratory diseases.

Competitive section

The main companies involved in the world respiratory inhalers market are AstraZeneca plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips NV, Merck & Co., Inc., OMRON Healthcare Europe BV, PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Key developments

Major market players are focusing on launching smart inhalers to expand their product portfolio. For example, in January 2019, FindAir, a European company developing digital systems for asthma and COPD control, launched its commercial FindAir ONE smart inhaler.

The major players in the market are also focusing on getting certification from regulatory bodies for their new inhalers. For example, in September 2019, Novartis International AGโ€™s Concept1 inhaler received certification under the new European Medical Device Regulation (MDR).

๐†๐ž๐ญ ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ ๐‚๐จ๐ฉ๐ฒ ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ: (๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐  ๐“๐Ž๐‚, ๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ & ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ, ๐‚๐ก๐š๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/227

Contents

  1. Research objective and hypothesis
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Abstract
      • Market extract, by product type
      • Market extract, by technology
      • Market extract, by disease indication
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Market dynamics
      • Drivers
      • Constraints
      • Market opportunities
    • Impact analysis
    • Key developments
    • Technological advance
    • Regulatory scenario
  4. Global respiratory inhalers market, by product type, 2017-2027 (USD Million)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Annual Growth Analysis, 2019-2027
      • Industry trends
    • dry powder inhaler
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
      • Industry trends
    • metered dose inhaler
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
      • Industry trends
    • Nebulizer
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
      • Industry trends
    • Ultrasonic Nebulizer
    • Compressed air nebulizer
    • Mesh Nebulizer
  5. Global respiratory inhalers market, by technology, 2017-2027 (USD Million)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Annual Growth Analysis, 2019-2027
      • Industry trends
    • Manual inhalers
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
    • Digitally controlled inhalers
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
  6. Global respiratory inhalers market, by disease indication, 2017-2027 (USD Million)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Annual Growth Analysis, 2019-2027
      • Industry trends
    • Asthma
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
    • COPD
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
    • Pulmonary arterial hypertension
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)
    • Others
      • introduction
      • Market size & forecast and annual growth, 2019-2027, (USD Million)

See the press release: https://www.coherentmarketinsights.com/press-release/respiratory-inhalers-market-to-surge-past-us-448-billion-by-2025-197

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. Weโ€™re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837